Business Description
Enzymatica AB
NAICS : 325412
SIC : 2834
ISIN : SE0003943620
Compare
Compare
Traded in other countries / regions
ENZY.SwedenEN9.GermanyEZYMF.USA IPO Date
2015-06-15Description
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.29 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 6.32 | |||||
| Beneish M-Score | -3.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year EBITDA Growth Rate | -17.1 | |||||
| 3-Year EPS without NRI Growth Rate | -14.9 | |||||
| 3-Year FCF Growth Rate | -18.1 | |||||
| 3-Year Book Growth Rate | -2.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.54 | |||||
| 9-Day RSI | 63.98 | |||||
| 14-Day RSI | 61.18 | |||||
| 6-1 Month Momentum % | -3.39 | |||||
| 12-1 Month Momentum % | -18.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 203.74 | |||||
| Days Sales Outstanding | 68.36 | |||||
| Days Payable | 87.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.8 | |||||
| Shareholder Yield % | -2.83 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.79 | |||||
| Operating Margin % | -104.84 | |||||
| Net Margin % | -108.27 | |||||
| ROE % | -68.9 | |||||
| ROA % | -38.46 | |||||
| ROIC % | -52.45 | |||||
| ROC (Joel Greenblatt) % | -314.36 | |||||
| ROCE % | -43.98 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.5 | |||||
| PB Ratio | 4.86 | |||||
| Price-to-Tangible-Book | 17.84 | |||||
| EV-to-EBIT | -9.26 | |||||
| EV-to-Forward-EBIT | -20.95 | |||||
| EV-to-EBITDA | -9.26 | |||||
| EV-to-Forward-EBITDA | 550.36 | |||||
| EV-to-Revenue | 9.66 | |||||
| EV-to-Forward-Revenue | 4.4 | |||||
| EV-to-FCF | -8.68 | |||||
| Price-to-Median-PS-Value | 1 | |||||
| Price-to-Net-Current-Asset-Value | 42.38 | |||||
| Earnings Yield (Greenblatt) % | -10.79 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzymatica AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 56.965 | ||
| EPS (TTM) (kr) | -0.37 | ||
| Beta | 0.11 | ||
| Volatility % | 52.11 | ||
| 14-Day RSI | 61.18 | ||
| 14-Day ATR (kr) | 0.376291 | ||
| 20-Day SMA (kr) | 3.21325 | ||
| 12-1 Month Momentum % | -18.13 | ||
| 52-Week Range (kr) | 2.1 - 5.35 | ||
| Shares Outstanding (Mil) | 164.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzymatica AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzymatica AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzymatica AB Frequently Asked Questions
What is Enzymatica AB(OSTO:ENZY)'s stock price today?
The current price of OSTO:ENZY is kr3.39. The 52 week high of OSTO:ENZY is kr5.35 and 52 week low is kr2.10.
When is next earnings date of Enzymatica AB(OSTO:ENZY)?
The next earnings date of Enzymatica AB(OSTO:ENZY) is 2023-11-02 Est..
Does Enzymatica AB(OSTO:ENZY) pay dividends? If so, how much?
Enzymatica AB(OSTO:ENZY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers